- Home
- CWT vs MLTX Comparison
CWT vs MLTX Comparison
Compare CWT & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CWT
- MLTX
- Stock Information
- Founded
- CWT 1926
- MLTX 2021
- Country
- CWT United States
- MLTX Switzerland
- Employees
- CWT N/A
- MLTX N/A
- Industry
- CWT Water Supply
- MLTX Biotechnology: Pharmaceutical Preparations
- Sector
- CWT Utilities
- MLTX Health Care
- Exchange
- CWT Nasdaq
- MLTX Nasdaq
- Market Cap
- CWT 2.8B
- MLTX 2.8B
- IPO Year
- CWT N/A
- MLTX N/A
- Fundamental
- Price
- CWT $46.57
- MLTX $53.72
- Analyst Decision
- CWT Strong Buy
- MLTX Strong Buy
- Analyst Count
- CWT 2
- MLTX 7
- Target Price
- CWT $54.50
- MLTX $74.83
- AVG Volume (30 Days)
- CWT 369.0K
- MLTX 476.8K
- Earning Date
- CWT 07-31-2025
- MLTX 08-05-2025
- Dividend Yield
- CWT 2.56%
- MLTX N/A
- EPS Growth
- CWT N/A
- MLTX N/A
- EPS
- CWT 2.28
- MLTX N/A
- Revenue
- CWT $990,685,000.00
- MLTX N/A
- Revenue This Year
- CWT N/A
- MLTX N/A
- Revenue Next Year
- CWT $7.46
- MLTX N/A
- P/E Ratio
- CWT $20.30
- MLTX N/A
- Revenue Growth
- CWT 0.63
- MLTX N/A
- 52 Week Low
- CWT $41.64
- MLTX $31.42
- 52 Week High
- CWT $56.25
- MLTX $58.26
- Technical
- Relative Strength Index (RSI)
- CWT 52.03
- MLTX 60.13
- Support Level
- CWT $46.21
- MLTX $54.00
- Resistance Level
- CWT $47.35
- MLTX $56.00
- Average True Range (ATR)
- CWT 0.88
- MLTX 2.12
- MACD
- CWT 0.08
- MLTX -0.04
- Stochastic Oscillator
- CWT 68.32
- MLTX 87.04
About CWT California Water Service Group
California Water Service Group is a U.S. water and utilities holding company based in California. The company engages in the production, treatment, storage, distribution, and sale of water for various uses. The firm operates through its subsidiaries, which can be divided between regulated and unregulated businesses. The regulated public utilities subsidiaries operate in California, New Mexico, Washington, and Hawaii. The unregulated subsidiaries provide water utility services to private companies and municipalities. The company derives the majority of its revenue from its operations in California and, overall, from residential customers.
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.